0001104659-20-118186.txt : 20201026
0001104659-20-118186.hdr.sgml : 20201026
20201026163508
ACCESSION NUMBER: 0001104659-20-118186
CONFORMED SUBMISSION TYPE: 3
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20201016
FILED AS OF DATE: 20201026
DATE AS OF CHANGE: 20201026
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: GILEAD SCIENCES INC
CENTRAL INDEX KEY: 0000882095
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 3
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37998
FILM NUMBER: 201261092
BUSINESS ADDRESS:
STREET 1: 333 LAKESIDE DR
CITY: FOSTER CITY
STATE: CA
ZIP: 94404
BUSINESS PHONE: 6505743000
MAIL ADDRESS:
STREET 1: 333 LAKESIDE DR
CITY: FOSTER CITY
STATE: CA
ZIP: 94404
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Jounce Therapeutics, Inc.
CENTRAL INDEX KEY: 0001640455
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 454870634
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 780 MEMORIAL DRIVE
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
BUSINESS PHONE: 857-259-3840
MAIL ADDRESS:
STREET 1: 780 MEMORIAL DRIVE
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
3
1
a3.xml
3
X0206
3
2020-10-16
0
0001640455
Jounce Therapeutics, Inc.
JNCE
0000882095
GILEAD SCIENCES INC
333 LAKESIDE DRIVE
FOSTER CITY
CA
94404
0
0
1
0
Common Stock
5539727
D
Gilead Sciences, Inc. By: /s/ Andrew D. Dickinson, Executive Vice President and Chief Financial Officer
2020-10-26